Frequency and duration of remission after isolated limb perfusion for melanoma.
暂无分享,去创建一个
P. Kam | K. Shannon | J. Thompson | P. Kam | J. Hunt | John F. Thompson
[1] A. Eggermont,et al. Repeat isolated limb perfusion with melphalan for recurrent melanoma of the limbs. , 1996, Journal of the American College of Surgeons.
[2] G. Balderson,et al. Hyperthermic isolated limb perfusion for malignant melanoma: Response and survival , 1995, World journal of surgery.
[3] R. Cavaliere,et al. Hyperthermic antiblastic perfusion in the treatment of stage IIIA-IIIAB melanoma patients. Comparison of two experiences. , 1994, Melanoma research.
[4] P. Kam,et al. Hyperthermic isolated limb perfusion in the treatment of melanoma : technical aspects , 1994 .
[5] A. Hart,et al. Prognostic factors for tumor response and limb recurrence-free interval in patients with advanced melanoma of the limbs treated with regional isolated perfusion with melphalan. , 1994, Surgery.
[6] R. Mirimanoff,et al. Regional therapy of melanoma. , 1993, European journal of cancer.
[7] J. Thompson,et al. Isolated limb perfusion for melanoma: Effectiveness and toxicity of cisplatin compared with that of melphalan and other drugs , 1992, World journal of surgery.
[8] J. Zee,et al. Results of a double perfusion schedule using high-dose hyperthermia and melphalan sequentially for recurrent melanoma of the limbs: a pilot study , 1992 .
[9] D. Coit. Hyperthermic isolation limb perfusion for malignant melanoma: a review. , 1992, Cancer investigation.
[10] J. Thomas,et al. Hyperthermic isolated perfusion with melphalan in the treatment of advanced malignant melanoma of the lower limb , 1990, The British journal of surgery.
[11] S. Carlini,et al. Prognostic variables in recurrent limb melanoma treated with hyperthermic antiblastic perfusion , 1989, Cancer.
[12] B. Kroon,et al. Regional isolation perfusion in melanoma of the limbs; accomplishments, unsolved problems, future. , 1988, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.
[13] D. Morton,et al. Value of therapeutic hyperthermic limb perfusion in advanced recurrent melanoma of the lower extremity. , 1985, American journal of surgery.
[14] P. Jönsson,et al. Results of regional hyperthermic perfusion for primary and recurrent melanomas of the extremities. , 1983, Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer.
[15] A. Verhest,et al. Objective regression of unexcised melanoma in-transit metastases after hyperthermic isolation perfusion of the limbs with melphalan. , 1983, Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer.
[16] E. V. van Slooten,et al. Dosimetry in isolation perfusion of the limbs by assessment of perfused tissue volume and grading of toxic tissue reactions. , 1982, European journal of cancer & clinical oncology.
[17] G. Westbury,et al. Isolated limb perfusion for malignant melanoma. , 1980, The Practitioner.
[18] G. Simert,et al. The effect of regional perfusion treatment on recurrent melanoma of the extremities. , 1977, Acta chirurgica Scandinavica.
[19] R. F. Ryan,et al. Chemotherapy of Cancer: Regional Perfusion Utilizing an Extracorporeal Circuit , 1958, Annals of surgery.